Ticker

Quarterly revenue for Q2 2026 was $734,028, representing a 43% year-over-year growth. Loss per share for Q2, 2026: ($0. 07) per share. Announced further signed in-network contracts and credentialing with major U. S.

Vancouver, British Columbia, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. ( CSE: AIDR , OTC: AIRDF , Frankfurt: 939 ) (“Rocket Doctor AI” or the “Company”) announces that it has granted an aggregate 24,000 stock options, exercisable at $0.70 per share and valid for a term of three years, and an aggregate 276,053 restricted share units, valid for a term between one to three years, to consultants of the…

Agreement provides Rocket Doctor access across five network channels, including commercial healthcare, Medicare Advantage, workers' compensation and auto medical. National network serves more than 700 health plans, over 100,000 employers and approximately 60 million consumers, creating a broad pathway for eligible patients to access physician-led care.

Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States

Rocket Doctor Inc. has been selected as one of Canada's Top 100 AI and Tech Startups, recognizing the Company's leadership in applying artificial intelligence to improve healthcare access and patient outcomes. Selected from more than 330 applicants, Rocket Doctor AI will showcase its AI-powered healthcare platform at ALL IN 2026, Canada's largest event dedicated to artificial intelligence and advanced technologies.